Stellaromics

Founded in 2022 and headquartered in Boston, Stellaromics is revolutionizing biomedical research with its proprietary technology, unraveling complex 3D transcription and translation patterns within native biological tissue.

Overview Structured Data Issues Contributors

stellaromics.com

Is a

Organization

Company

Company attributes

Industry

Location

Natick, Massachusetts

B2X

B2B

CEO

‌

Todd Dickinson

Number of Employees (Ranges)

11 – 50

Email Address

info@stellaromics.com

Investors

‌

Catalyst4

Stanford University Press

Total Funding Amount (USD)

80,000,000

Latest Funding Round Date

February 11, 2025

CTO

‌

Ye Fu

Latest Funding Type

Series B

Other attributes

Latest Funding Round Amount (USD)

80,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Stellaromics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.